Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05254340 · ClinicalTrials.gov registry record · NA

Healthy Volunteer Short Chain Fatty Acid Study

A NA study, sponsored by Indiana University.

Terminated
Registry status
NA
Development phase
29
Enrollment target

NCT05254340 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 29 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05254340, a NA study, was terminated before completion, sponsored by Indiana University.

TERMINATED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the production of short chain fatty acids (fatty acids are part of your diet) in stool through the measurement of fecal inulin after a one-time ingestion of 10-gram dose of inulin among healthy adult volunteers.

Interventions

  • DIETARY_SUPPLEMENT Inulin

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2021-08-01
Est. Completion 2023-07-31
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT05254340

The ClinicalTrials.gov registry entry for NCT05254340 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Inulin is the first listed.

NCT05254340 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05254340 about?

NCT05254340 is a clinical study titled "Healthy Volunteer Short Chain Fatty Acid Study". The purpose of this study is to evaluate the production of short chain fatty acids (fatty acids are part of your diet) in stool through the measurement of fecal inulin after a one-time ingestion of 10-gram dose of inulin among healthy adult volunteers.

What is the current status of trial NCT05254340?

This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2021-08-01. Estimated completion is 2023-07-31.

What interventions are being tested in trial NCT05254340?

The interventions under investigation include: Inulin (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05254340?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.